chalcone has been researched along with Cancer of Esophagus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Ge, C; He, R; Jin, Y; Wu, H; Yang, Y; Zhou, B; Zou, X | 1 |
| Chen, J; Kang, CY; Niu, ZX; Yang, HM; Zhou, HC | 1 |
| Chen, X; Gao, Y; Wang, Y; Zhang, L | 1 |
3 other study(ies) available for chalcone and Cancer of Esophagus
| Article | Year |
|---|---|
A novel synthetic chalcone derivative, 2,4,6-trimethoxy-4'-nitrochalcone (Ch-19), exerted anti-tumor effects through stimulating ROS accumulation and inducing apoptosis in esophageal cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chalcone; Chalcones; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Mice; Mice, Nude; Reactive Oxygen Species; Signal Transduction | 2022 |
A chalcone inhibits the growth and metastasis of KYSE-4 esophageal cancer cells.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Chalcone; Chalcones; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Humans | 2020 |
Hydroxysafflor Yellow A of Carthamus Tinctorius L., Represses the Malignant Development of Esophageal Cancer Cells via Regulating NF-κB Signaling Pathway.
Topics: Antineoplastic Agents; Apoptosis; Carcinogenesis; Carthamus tinctorius; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chalcone; Drug Discovery; Esophageal Neoplasms; Humans; Intercellular Adhesion Molecule-1; Matrix Metalloproteinase 9; Neoplasm Invasiveness; NF-kappa B; Quinones; Signal Transduction; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2020 |